X4 Pharmaceuticals, Inc. · NASDAQ:XFOR

Kirske David sold 11,767 X4 Pharmaceuticals, Inc. shares (Form 4)

Traded Oct 1, 2026 · Filed Oct 5, 2026

On Oct 1, 2026, Kirske David (Chief Financial Officer) sold 11,767 X4 Pharmaceuticals, Inc. shares at US$2.86 for US$33,658, leaving 155,983 shares. Filed Oct 5, 2026 (Form 4).

Sold
11,767 shares
Price
US$2.86
Value
US$33,658
Holding after
155,983 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 1, 2026Common StockSale11,767US$2.86155,983Direct

Source

View original at SEC

Related